NCT04298619View on ClinicalTrials.gov

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2019

Conditions
Hodgkin LymphomaHigh RiskRelapse
Interventions
DIAGNOSTIC_TEST

Standard cohort: Clinical lab follow-up

DIAGNOSTIC_TEST

Imaging cohort: integrated imaging follow-up

All Listed Sponsors
lead

Federico II University

OTHER

NCT04298619 - Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission | Biotech Hunter | Biotech Hunter